Factors associated with patient preferences for statin therapy in primary prevention
Yan Luo, Hiroshi Kawakami, Satoshi Funada, Shoma Ozawa, Ethan Sahker, Kenji Omae, Kazumichi Yamamoto, Osamu Yamaguchi, Aran Tajika, Toshi A Furukawa · 2026
Read Factors associated with patient preferences for statin therapy in primary prevention by Yan Luo, Hiroshi Kawakami, Satoshi Funada, Shoma Ozawa, Ethan Sahker, Kenji Omae, Kazumichi Yamamoto, Osamu Yamaguchi, Aran Tajika, Toshi A Furukawa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13633888.txt.
Description
Yan Luo and nine colleagues published this 2026 survey study on how much benefit people demand before they will take a statin. The smallest worthwhile difference is the least gain a person finds worth a treatment's burdens. The question matters because statins prevent heart attacks in healthy people, yet many decline them. More than twelve hundred adults in the United States and Japan weighed three risk scenarios using a structured trade-off method.
Across every scenario, the typical demanded benefit was larger than what statins usually deliver. People who saw their own risk as higher asked for less benefit in return. Current statin users and people with a high cholesterol history also settled for less. Prior education about cholesterol lowered the demanded benefit in both countries. The authors argue that honest conversations about personal risk and real benefit size could bring patient choices closer to what studies show.
Catalog record
| CREATOR | Yan Luo, Hiroshi Kawakami, Satoshi Funada, Shoma Ozawa, Ethan Sahker, Kenji Omae, Kazumichi Yamamoto, Osamu Yamaguchi, Aran Tajika, Toshi A Furukawa |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |